VBIO: Wolf Lisa G is leaving
(b) On October 31, 2026, Lisa Wolf notified the Special Committee of the Board of Directors of Valion Bio, Inc. (the “Company”) of her decision to voluntarily resign from her positions as President, Chief Operating Officer and Chief Financial Officer of the Company. Ms. Wolf’s resignation from each of these positions will become effective on December 11, 2026. Accordingly, as of the date of this Current Report on Form 8-K, Ms. Wolf’s resignation has not yet become effective. 2
Companies/Indices · Leadership · SEC Form 8-K (item 5.02) · 4 Nov 2026
Companies named: VBIO